Professor of Medicine, Johns Hopkins University School of Medicine
Infectious Disease
Dr. Richard E. Chaisson, MD
|
|
Give Review
Richard Chaisson is an expert in the field of Infectious Disease. He studied medicine at University of Massachusetts Medical School. University of Massachusetts Medical School has a rank of 49 in research and a 12 in primary care Richard Chaisson is also a published doctor. He has 100 paper published. The most recent paper is: Three months of weekly rifapentine plus isoniazid for treatment of M. tuberculosis infection in HIV co-infected persons.
Publications
- Undiagnosed TB in adults dying at home from natural causes in a high TB burden setting: a post-mortem study.
- Latent tuberculous infection in schoolchildren and contact tracing in Matlosana, North West Province, South Africa.
- Shortening tuberculosis treatment with fluoroquinolones: lost in translation?
- Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.
- Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection.
- Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
- Long-term Protection From Isoniazid Preventive Therapy for Tuberculosis in HIV-Infected Patients in a Medium-Burden Tuberculosis Setting: The TB/HIV in Rio (THRio) Study.
- Preventing Tuberculosis Among HIV-Infected Pregnant Women in Lesotho: The Case for Rolling Out Active Case Finding and Isoniazid Preventive Therapy.
- Prevalent Tuberculosis (TB) at HIV diagnosis in Rio de Janeiro, Brazil: The TB/HIV in Rio (THRio) Cohort.
- Taking the long view on the CREATE studies' findings.
- Impact of Isoniazid Preventive Therapy for HIV-Infected Adults in Rio de Janeiro, Brazil: An Epidemiological Model.
- Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.
- A trial of mass isoniazid preventive therapy for tuberculosis control.
- Understanding and retention of trial-related information among participants in a clinical trial after completing the informed consent process.
- Tuberculosis control in a socially vulnerable area: a community intervention beyond DOT in a Brazilian favela.
- Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Br...
- Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
- Quality of life among people treated for tuberculosis and human immunodeficiency virus in Rio de Janeiro, Brazil [Short communication].
- Mortality associated with delays between clinic entry and ART initiation in resource-limited-settings: results of a transition-state model.
- Patient-Nominated, Community-Based HIV Treatment Supporters: Patient Perspectives, Feasibility, Challenges, and Factors for Success in HIV-Infected South African Adults.
- The Association between Symptoms and Microbiologically Defined Response to Tuberculosis Treatment.
- Post-2015 tuberculosis strategies in a pre-2015 world [Editorial].
- Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in Brazil.
- Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence.
- The ethics of testing a test: randomized trials of the health impact of diagnostic tests for infectious diseases.
- Community-based Targeted Case-finding for Tuberculosis and HIV in Household Contacts of Tuberculosis Patients in South Africa.
- Interferon-gamma release assay versus tuberculin skin test across RA, PsA, and AS patients prior to treatment with golimumab, a human anti-TNF antibody.
- Changing predictors of mortality over time from cART start: implications for care.
- Diagnostic Accuracy of a Urine Lipoarabinomannan Enzyme-Linked Immunosorbent Assay for Screening Ambulatory HIV-Infected Persons for TB.
- New regimens to prevent tuberculosis in adults with HIV infection.
- Epidemiology of Tuberculosis and HIV: Recent Advances in Understanding and Responses.
- Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South ...
- Survival in XDR TB: Shifting the Curve and Shifting the Paradigm.
- Active Tuberculosis Case-Finding among Pregnant Women Presenting to Antenatal Clinics in Soweto, South Africa.
- Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil.
- Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence.
- Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis.
- HIV infection-related tuberculosis: clinical manifestations and treatment.
- Recurrent tuberculosis: relapse, reinfection, and HIV.
- Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa.
- Tuberculosis and diabetes mellitus: convergence of two epidemics.
- Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
- Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.
- Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
- Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health.
- Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users.
- Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program.
- Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality ...
- Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil.
- Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
- Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing.
- A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa.
- Tuberculosis in Africa--combating an HIV-driven crisis.
- AIDS-related tuberculosis in Rio de Janeiro, Brazil.
- Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults.
- Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
- Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin.
- Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities.
- Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
- Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.
- From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis.
- Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study.
- Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.
- Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
- Combining PMTCT with active case finding for tuberculosis.
- Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
- Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.
- Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.
- HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and practices in HIV-infected adults in Soweto, South Africa.
- The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
- Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.
- Does tuberculosis increase HIV load?
- Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
- Gender differences in indices of opioid dependency and medical comorbidity in a population of hospitalized HIV-infected African-Americans.
- Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.
- Differences in HIV disease progression by injecting drug use in HIV-infected persons in care.
- Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic su...
- Treatment of chronic infections with rifamycins: is resistance likely to follow?
- The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons.
- Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study.
- Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.
- Tuberculosis chemotherapy: still a double-edged sword.
- Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity.
- Tuberculosis drug resistance: a global threat.
- Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis.
- Comparison of C(18)-carboxypropylbetaine and standard N-acetyl-L-cysteine-NaOH processing of respiratory specimens for increasing tuberculosis smear sensitivity in Bra...
- Hepatitis C and progression of HIV disease.
- Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners.
- Selected topics from the 9th Conference on Retroviruses and Opportunistic Infections.
- Field evaluation of a rapid immunochromatographic test for tuberculosis.
- Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations.
- TB and HIV: challenges and progress.
- Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy.
- Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors.
- Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program.
- Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.
- Tuberculosis screening in an at-risk immigrant Hispanic population in Baltimore city: an academic health center/local health department partnership.
- CD4 and Viral Load Dynamics in Antiretroviral-Naïve HIV-Infected Adults from Soweto, South Africa: A Prospective Cohort.
- Three months of weekly rifapentine plus isoniazid for treatment of M. tuberculosis infection in HIV co-infected persons.
Schools
University of Massachusetts Worcester Campus
Doctors Specialties
- Internal Medicine
- Infectious Disease
Accepted Insurances
Education
-
UCSF -
University of Massachusetts Medical School
Hospital
-
Johns Hopkins Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Jonathan D. Rich, DO |
|
|
Dr. Sandra Groot, MD |
|
|
Dr. Constance W. Hwang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wilbur H. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip A. Mackowiak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kent E. Kester, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Zenilman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael E. Kleinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ikwo K. Oboho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dimitra Mitsani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Greenough, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clare Rock, MD
This Doctor is OpenDoctor Recommended.
|